Rawlinson, R., & Massey, A. J. (2014). γH2AX and Chk1 phosphorylation as predictive pharmacodynamic biomarkers of Chk1 inhibitor-chemotherapy combination treatments. BioMed Central.
Styl ChicagoRawlinson, Rebecca, a Andrew J. Massey. γH2AX and Chk1 Phosphorylation As Predictive Pharmacodynamic Biomarkers of Chk1 Inhibitor-chemotherapy Combination Treatments. BioMed Central, 2014.
Citace podle MLARawlinson, Rebecca, a Andrew J. Massey. γH2AX and Chk1 Phosphorylation As Predictive Pharmacodynamic Biomarkers of Chk1 Inhibitor-chemotherapy Combination Treatments. BioMed Central, 2014.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..